经股动脉血管支架置入术治疗腹主动脉瘤:并发症和再次介入治疗

此研究目的是确定腹主动脉瘤支架置入术并发症的发生率和评估再次介入治疗的作用。29例肾动脉下腹主动脉瘤适合于支架置入术。复查方法包括螺旋CT和静脉法数字减影血管造影。复查病例27例,平均复查时间为8.2个月(1周～15个月)。1例在支架置入术前死于心力衰竭。置入分叉状支架的17例中2例用改良法支架释放术失败;2例支     

跨肾动脉放置覆膜内支架治疗腹主动脉瘤对肾动脉开放的影响

目的 :血管内覆膜内支架放置修补术治疗腹主动脉瘤要求近端瘤颈长度 15～ 2 0mm。通过比较术前术后DSA和CT结果 ,探讨跨肾动脉放置支架治疗短瘤颈的腹主动脉瘤对肾动脉的影响。方法 :13例腹主动脉瘤患者行经皮血管内覆膜内支架修补术 ,支架的裸露部分跨过肾动脉开口位置。术前 1周内DSA 13例 ,术后DSA 2 0例。采用多层面螺旋CT或双螺旋CT ,增强扫描图像采用MIP重建腹主动脉和肾动脉。结果 :近端瘤颈长度 5 .0～ 3 0 .3mm (平均 18.5mm )。术前DSA示 2例患者 3支肾动脉狭窄 ,其中左侧 1支 ,右侧 2支 ,狭窄程度约 5 0 %。术后DSA显示 2 5支肾动脉开口均为支架裸露部分遮盖 ,2例共 3支肾动脉狭窄 ,与术前比较 ,狭窄的部位与程度均无明显变化。术前CTMIP显示4支肾动脉狭窄 ,管腔直径狭窄程度约 5 0 %。术后 1个月CTMIP显示 3例出现内漏 ,4支肾动脉狭窄 ,狭窄程度无明显变化。 3个月后 ,12例CT检查未出现新的狭窄。结论 :跨肾动脉放置覆膜内支架治疗腹主动脉瘤对肾动脉形态学无明显影响 ,对具有一种以上外科手术高危因素的患者是一种有效的介入治疗方法     

多层螺旋CT造影在主动脉病变腔内修复术后随访的价值

目的:探讨多层螺旋CT血管造影(multi-detector rowspiral computed tomography angiography,MDCTA)及后处理技术在主动脉覆膜支架腔内修复术(transluminal stent-graft placement,TSGP)术后随访的临床应用价值。方法:21例接受TSGP主动脉疾病患者,包括:Stanford B型夹层13例,真性动脉瘤3例,假性动脉瘤2例,弓降部穿透性溃疡1例,胸主动脉瘤合并局限性夹层1例,胸主动脉瘤合并Stanford B型夹层1例,术后采用MDCTA进行随访,平均随访13个月(1~24个月)。采用轴位图像与多种重建图像相结合来显示支架形态、术前术后主动脉管腔情况的变化和有无并发症。结果:13例主动脉夹层覆膜支架置入后:所有患者均真腔扩大,假腔减小或消失并伴血栓形成,支架未发现移位或断裂;共3例(14%)随访中发现内漏,1例Ⅱ型内漏,建议随访观察;1例术后8个月复查新发现支架近端Ⅰ型内漏,密切随访2个月后患者出现胸痛,复查CT内漏增多,转外科治疗。1例腹主动脉瘤术后1月复查发现Ⅲ型内漏。所有患者介入术后CT随访图像均满足临床诊断需要。结论:MDCTA对主动脉覆膜支架置入术后随访较其他检查手段具有多方面的优越性,能及时观察术后疗效、发现并发症,对主动脉疾病覆膜支架腔内修复术后随访具有重要价值。     

无创性血管弹性成像对犬腹主动脉瘤腔内修复术后的随访观察

正摘要目的评估无创性血管弹性成像在评价犬腹主动脉瘤腔内支架修复术后内漏及血栓形成的能力,并以CT及病理做参照。材料与方法所有模型均经动物管理协会及加拿大动物管理委员会同意。18例狗腹主动脉瘤模型均置入支架。伴Ⅰ型内漏的动脉瘤有4例,Ⅱ型内漏13例,无内漏者1例。在手术当天及术后1周、1个月、3个月、6个月均用     

血管塞治疗腹主动脉瘤主动脉腔内修复术后高流量Ⅰ型内漏4例

目的 探讨血管塞治疗腹主动脉瘤主动脉腔内修复术后高流量Ⅰ型内漏的可行性和安全性.方法 回顾性分析2019年5月至9月收治的腹主动脉瘤主动脉腔内修复术患者临床资料,其中3例腹主动脉瘤术后即刻造影发现Ⅰa型内漏,1例腹主动脉瘤术后3个月复查CT发现Ⅰb型内漏.4例腹主动脉瘤主动脉腔内修复术后高流量Ⅰ型内漏患者均接受血管塞栓...     

腹主动脉瘤腔内隔绝术后迟发型远端内漏Ⅱ期腔内治疗

目的：探讨腹主动脉瘤（AAA）腔内隔绝术EVE后迟发型远端内漏的Ⅱ期腔内治疗方法的价值。方法：为3例AAA EVE3年以后迟发型远端内漏患者进行了Ⅱ期延伸移植物置入治疗，2例经双侧动脉切开、两侧各置入1枚延伸移植物，1例经腹膜后径路和股动脉径路完成3枚延伸移植物置入。结果：3例均应用了贯穿导丝牵张技术，延伸移植物置入完成后均将内漏消除。结论：Vanguard支架-人造血管系统的结构特点可能是导致远期远端内漏的原因；延伸移植物是治疗的有效方法。导丝牵张技术有助于手术成功并节约手术时间。     

多层螺旋CT血管造影在主动脉瘤腔内带膜内支架置入术后并发症诊断中的应用

目的：探讨多层螺旋CT血管造影（CTA）在主动脉瘤腔内带膜内支架置入术后并发症诊断中的应用。方法：31例腹主动脉瘤和主动脉夹层腔内带膜内支架置入术后行多层螺旋CT血管造影，采用准直2.5mm，层厚3.0mm，螺矩6-8，重建方法为容积显示（VR）、表面遮盖显示（SSD）、最大密度投影法（MIP）及多层面重建法（MPR）。观察图像确定有无术后并发症，并比较4种重建方法对并发症的显示情况。结果：31例中有1例术后内支架出现局限性断裂，VR、MIP及MPR均清晰显示了内支架的变化，SSD未能显示。1例内支架展开不良，4种重建方法均明确显示；5例术后出现渗漏，VR及MPR清晰显示渗漏的部位、形态及内漏量，MIP、SSD仅显示其中的4例。在显示支架内血流情况及瘤周血栓方面，VR及MPR能明确支架内有无血栓形成及腔内带膜内支架置入术后的转归变化，VR及MPR显示1例术后支架内血栓形成，SSD及MIP未能显示。结论：多层螺旋CTA有利于主动脉瘤腔内带膜内支架置考试术后并发症的诊断；VR及MPR图像优于SSD及MIP，能为术后内支架情况作出更准确的判断 。     

螺旋CT在腹主动脉瘤内支架治疗后随访中的应用

目的：评价螺旋CT在腹主动脉瘤内支架治疗术后随访中的作用。方法：30例内支架置入术后,26例患者在3d内进行了CT检查;另外,22例患者3个月后进行了CT复查。对动脉瘤的大小、术后合并症、支架的位置、形态和通畅情况做了观察。结果：术后3d,26例中有20例动脉瘤完全闭塞,6例有漏血。3个月后,17例闭塞的动脉瘤,9例直到缩小,7例无变化,1例增大;在5例漏血病例中,2例动脉瘤直径缩小,2例无变化,1例增大。手术成功率为76．92％。结论：螺旋CT是腹主动脉瘤内支架术后随访中很有价值的方法。     

国产镍钛合金血管内裸支架治疗囊形腹主动脉瘤的实验研究

目的 研究、观察国产血管内支架治疗犬腹主动脉瘤的疗效。方法 采用简单随机分组方法，将健康杂种犬32只随机分为4组，每组8只。组1；对照组，未置入支架；组2：实验组，腹主动脉前壁纵行切口长度≤1cm，置入支架治疗；组3：实验组，腹主动脉前壁纵行切口长度＞1cm且≤2cm，置入支架治疗；组4：实验组，腹主动脉前壁纵行切口长度≥3cm，置入支架治疗。外科方法建立腹主动脉瘤模型后2周行介入治疗。术后每个月行增强CT检查；第6个月处死时，行腹主动脉造影检查。结果 组1在6个月观察期内，CT和腹主动脉造影检查均示瘤腔存在。组2于第1个月CT检查时发现有1只犬瘤腔闭合；第2个月CT检查时有4只犬瘤腔闭合；第3个月有2只犬瘤腔闭合；条4个月有1只犬瘤腔闭合；第6个月腹主动脉造影检查也证实瘤腔闭合。组3CT检查和腹主动脉造影检查发现每只犬均残留有1个小瘤腔，且瘤壁呈向心性增厚。组4CT检查和腹主动脉造影检查发现每只犬均显示有1个大瘤腔。32只犬的腹主动脉均通畅。结论 国产镍钛合金血管内裸支架，对瘤颈直径≤1cm的腹主动脉瘤有治疗作用；对瘤颈直径＞1cm且≤2cm者，可防止动脉瘤继续扩张和迟发破裂；对瘤颈直径≥3cm者则无任何治疗作用。     

多层螺旋CT血管造影对腔内隔绝术后内漏的诊断价值

目的 探讨多层螺旋CT血管造影(MSCTA)对腔内隔绝术后内漏的诊断价值。方法105例腹主动脉瘤和主动脉夹层腔内隔绝术后行MSCTA，采用准直2.5mm，层厚3．0mm，螺距为6，重建方法为容积显示技术、表面遮盖显示、最大密度投影法及多层面重建法。观察分析原始图像及三维重建图像，确定有无内漏、内漏的类型及漏出量。结果 105例中有13例术后出现内漏，发生率为12．4％，其中，8例为腹主动脉瘤腔内隔绝术后，5例为主动脉夹层术后；Ⅰ型内漏8例，Ⅱ型2例，Ⅲ型3例。结论 MSCTA有利于腔内隔绝术后内漏的诊断，应作为腔内隔绝术后诊断内漏等并发症的主要影像检查方法。     

Rational radiologic after-care of endoluminal aortic bypass

Goal. To identify essential and relevant diagnostic algorithms in the follow-up of stent-grafts placed for aortic dissections and aneurysms based on our 7 years experience including the use of more than 10 different devices. Material and Methods. Evaluation of conventional biplane imaging, angiography, sonography, CT and MR in the efficacy of demonstrating endoleaks, sac shrinkage, changes of stent-graft integrity and, with special reference to MR-compatibility of various stent-graft devices. Results. Endoleaks are found in 20–30% of patients after endovascular exclusion of abdominal aortic aneurysms. However, this rate neither necessarily reflects the clinical course nor the onset and course of sac shrinkage. Physical long-term integrity of the devices is seen best on conventional bi-plane radiographs. Sonography is helpful only in selected patients (non-obese, good compliance) otherwise not providing information precisely enough for sac control. As gold standard both CT (CTA) and MR (MRA) are equally effective in the follow-up of endovascular stent-grafts, allowing 3D control of sac geometry in aneurysmal disease or hemodynamic changes in stent-grafts for aortic dissection. MRI is considered to be more effective in the detection of small endoleaks. Angiography is inferior to CT and MRI in the diagnosis of endoleaks and thus is required only for intervention planning in patients with suspected endoleaks. Two of 8 evaluated stent-graft devices proved to be prohibitive for MRI because of their severe artifacts productions (Life-path, Zenith) as a result of their thick metallic meshwork. Conclusion. CT including CTA with 2D and 3D reformatting is the method of choice for the follow up of stent-graft treatment of aortic disease. Depending on availability, MRI may be used alternatively. In young patients and for those with contraindications to iodinated contrast media MRI is a perfectly equivalent alternative. Especially in patients with known contraindications to iodinated contrast media the MR-compatibility should be taken into consideration in the choice of the endovascular device.     

Percutaneous treatment of infrarenal aortic aneurysm with a polytetrafluoroethylene-covered nitinol stent-graft via a 10-F introducer sheath

Two patients with dissecting (n = 1) and saccular (n = 1) aneurysms of the infrarenal abdominal aorta with very narrow proximal and distal aortic necks underwent treatment with percutaneous implantation of self-expandable polytetrafluoroethylene (PTFE)-covered nitinol stent-grafts on an off-label basis. The stent-grafts had maximum diameters of 13.5 mm and were deployed via 10-F introducer sheaths. Complete coverage of both aneurysms was achieved without evidence of endoleaks. The only complication observed was a pseudoaneurysm of the femoral access site in one patient, which was treated conservatively. Based on the experience described in this report, an aortic aneurysm with a narrow aortic neck can be safely treated with a PTFE-covered nitinol stent-graft.     

Type IIIb Endoleak Is Not Extremely Rare and May Be Underdiagnosed after Endovascular Aneurysm Repair

PurposeTo investigate the real incidence of type IIIb endoleaks associated with the Zenith stent graft, currently the most widely used third-generation polyester stent graft, in a Japanese multicenter database.Materials and MethodsRetrospective analysis was conducted of 433 patients who underwent endovascular aneurysm repair (EVAR) of aortoiliac aneurysms with the use of Zenith stent grafts from 2007 to 2016. The mean age of patients was 75.6 y ± 7.8, and 85.2% of patients were men. Mean transverse diameters of abdominal aortic aneurysms and common iliac artery aneurysms were 50.8 mm ± 9.9 and 42.2 mm ± 10.3, respectively.ResultsDuring a mean follow-up period of 41.9 mo, 7 type IIIb endoleaks (1.6%) were identified. Four patients were definitively diagnosed during repeat intervention, and 3 were diagnosed based on postoperative CT images. Three patients were treated surgically, 2 were treated by relining with an additional stent graft, and 2 were conservatively followed with CT imaging. Only 1 of 5 patients who underwent repeat intervention had a preoperative diagnosis of type IIIb endoleak, reflecting the difficulty in its diagnosis.ConclusionsThe incidence of type IIIb endoleak in Zenith stent grafts was 1.6% in this study, suggesting that type IIIb endoleaks are not extremely rare. In addition, type IIIb endoleak may be underdiagnosed or misdiagnosed as a different type of endoleak. Type IIIb endoleaks should always be considered in patients with sac expansion after EVAR.     

Midterm follow-up of a single-center experience of endovascular repair of abdominal aortic aneurysms with use of the Talent stent-graft

PURPOSE: To review the midterm results of endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs) with the Talent stent-graft. MATERIALS AND METHODS: All patients who underwent EVAR of AAAs with Talent stent-grafts from February 1998 to April 2002 at a single institution were monitored for a minimum of 2 years or until an endpoint of death or rupture was reached. RESULTS: There were 68 eligible patients, who were monitored for a mean period of 39 months (range, 24-72 months). Forty-nine (72.9%) were alive at 2 years; among the 19 deaths, two resulted from aneurysm rupture and the other 17 were unrelated to EVAR. There was one immediate conversion to open repair and five primary proximal endoleaks; the remaining 62 patients (91.2%) all had a technically successful procedure. There were 33 endoleaks during follow-up: 23 (69.7%) were treated conservatively and 10 (30.3%) underwent secondary intervention in the form of embolization (n=2), attempted embolization (n=2), endovascular stent-graft placement (n=3), combined stent-graft placement and embolization (n=1), or surgical conversion (n=2). Overall, there were five persistent endoleaks, and the remaining patients were free of endoleak at their last review or endpoint. Three stent-grafts migrated and required further endovascular intervention. Wire fracture was seen in two stents but presented no clinical sequelae. There was one case of graft limb thrombosis that required surgical thrombectomy. CONCLUSIONS: EVAR of AAAs with use of the Talent stent-graft is a promising and acceptable alternative to open surgery. Our 30-day mortality rate of zero compares extremely well with historical data from open surgery and the findings of more recently published trials. The risk of endoleak and uncertainty over durability require long-term surveillance.     

Emergency Endovascular Treatment of Abdominal Aortic Aneurysms: Feasibility and Results

Purpose To assess the feasibility and effectiveness of emergency endovascular treatment of abdominal aortic aneurysms (AAAs). Methods During 36 months we treated, on an emergency basis, 30 AAAs with endovascular exclusion. In 21 hemodynamically stable patients preoperative CT angiography (CTA) was performed to confirm the diagnosis and to plan the treatment; 9 patients with hemorrhagic shock were evaluated with angiography performed in the operating room. Twenty-two Excluder (Gore) and 8 Zenith (Cook) stent-grafts (25 bifurcated and 5 aorto-uni-iliac) were used. The follow-up was performed by CTA at 1, 3, 6, and 12 months. Results Technical success was achieved in 100% of cases with a 10% mortality rate. The total complication rate was 23% (5 increases in serum creatinine level and 2 wound infections). During the follow-up, performed in 27 patients (1–36 months, mean 15.2 months), 4 secondary endoleaks (15%) (3 type II, 2 spontaneously thrombosed and 1 under observation, and 1 type III treated by iliac extender insertion) and 1 iliac leg occlusion (treated with femoro-femoral bypass) occurred. We observed a shrinkage of the aneurysmal sac in 8 of 27 cases and stability in 19 of 27 cases; we did not observe any endotension. Conclusions Endovascular repair is a good option for emergency treatment of AAAs. The team’s experience allows correct planning of the procedure in emergency situations also, with technical results comparable with elective repair. In our experience the bifurcated stent-graft is the device of choice in patients with suitable anatomy because the procedure is less time-consuming than aorto-uni-iliac stent-grafting with surgical crossover, allowing faster aneurysm exclusion. However, further studies are required to demonstrate the long-term efficacy of endovascular repair compared with surgical treatment.     

Helical CT angiography of stent-grafts in abdominal aortic aneurysms: morphologic changes and complications.

Transfemoral placement of an endovascular stent-graft is increasingly be-ing used as an alternative to surgical repair in the treatment of abdominal aortic aneurysm, especially in high-risk patients. However, complications frequently occur after stent-graft placement. Helical computed tomographic (CT) angiography is a fast, minimally invasive procedure that is quickly becoming the imaging modality of choice for assessment of these complications. Thirty-nine patients who were treated for abdominal aortic aneurysm with stent-graft placement underwent helical CT angiography at routinely scheduled follow-up intervals or whenever complications were suspected. The resulting images were evaluated for the presence, extent, and origin of endovascular leaks. In addition, the position, shape, and patency of the stent-grafts were assessed. Findings included both graft-related (n = 4) and non-graft-related (n = 3) leaks, thrombosis of a graft limb (n = 3), distal migration of the stent-graft (n = 5), angulation of bifurcated stent-grafts distal to the main graft (n = 6), shrinkage of the abdominal aortic aneurysm (n = 7), enlargement of the aneurysm with secondary graft-related leaks (n = 2), and an aortoduodenal fistula (n = 1). Helical CT angiography can depict complications that develop after treatment of abdominal aortic aneurysms with endovascular stent-grafts. Long-term follow-up is required to determine the full spectrum and frequency of complications that may develop after initially successful repair.     

Endovascular Treatment of Mycotic Aortic Pseudoaneurysms with Stent-Grafts

Mycotic aortic aneurysms remain a therapeutic challenge, especially in patients who are not suitable for open surgery. Endovascular treatment with stent-grafts in this indication is still disputed. Between January 2002 and January 2006, six patients with mycotic aneurysms of the thoracoabdominal or abdominal aorta were admitted to our department. All patients were male, aged 57–83 years (mean, 74.6 years). The mycotic aneurysms were diagnosed on the basis of clinical signs of infection, on CT, and, in four cases, on a positive blood culture. In all patients the mycotic aortic aneurysms were treated endovascularly by stent-graft implantation. Technical and clinical success was achieved in all patients. There was no in-hospital or 30-day mortality. In the follow-up period (range, 2–47 months) four patients died of cancer, cardiac failure, or unknown cause (one case). Two patients are still alive with nearly complete regression of the aneurysms. We conclude that treatment of mycotic aortic aneurysms with stent-grafts may be an alternative in selected patients.     

Concepts for optimizing stent graft treatment of abdominal aortic aneurysms based on results of animal experiments

PURPOSE: In the endoluminal therapy of abdominal aortic aneurysms, a short proximal aneurysm neck, endoleaks and the large size and stiffness of the introducer systems are responsible for many of the complications and sub-optimal outcomes. The purposes of the present review article is to to suggest strategies to minimize these complications based on the results of experimental studies in animals. MATERIAL AND METHODS: After implanting various types of stents across the renal artery origins, the functional and morphological changes in the kidneys and renal vessels were studied by various authors. In order to prevent progressive widening of the proximal aneurysmal neck and graft dislocation, Sonesson et al. performed a laparoscopic banding around the proximal neck in pigs. To study the effects of endoleaks, Marty, Schurink and Pitton carried out pressure measurements in experimental aneurysms with and without endoleaks. Sakaguchi und Pavcnik developed the "Twin-tube endografts" (TTEG) and the "Bifurcated drum occluder endografts" (BDOEG) and tested them in dogs. RESULTS: Up to 3 months after suprarenal stent placement, Chavan et al. detected no significant fall in the mean inulin clearance in sheep (140 +/- 46 ml/min before, 137 +/- 58 ml/min after). Nasim et al. and Malina et al. reported similar observations with respect to renal function. Suprarenal fixation may result in isolated thrombotic occlusions of the renal arteries and microinfarcts in the kidneys. Mean aortic diameters at the level of banding were significantly smaller in the animals with aortic banding as opposed to those in the control group without banding (8 mm vs 11 mm, p = 0.004). The banding caused a secure proximal fixation of the stent-graft. Persistent endoleaks resulted in significantly higher intraaneurysmal pressures. Although the TTEG and the BDOEG stent-grafts required smaller sheaths, occlusions were observed in 8% (TTEG) and 60% (BDOEG) of the graft limbs. DISCUSSION: Supra-renal fixation of the stent-graft does not significantly affect renal function. Depending partly on the stent-graft-Design, isolated microinfarcts in the kidneys or thrombotic occlusions of the renal arteries may occur. A laparoscopic banding of the aorta at the proximal neck after graft implantation could prevent widening of the proximal neck and graft dislocation with the passage of time. To reduce the incidence of endoleaks, embolization of large branches, particularly those arising from aneurysms without mural thrombus is advisable. Due to the relatively high rate of occlusion of the graft limbs, the TTEG and the BDOEG stent-graft designs still require refinement. A rational application of the results of these animal experimental studies in clinical practice could markedly improve the long-term results of endoluminal stent grafting of abdominal aortic aneurysms.     

Transrenal fixation of aortic stent-grafts: short- to midterm effects on renal function--a systematic review

PURPOSE: To perform a systematic review of the short- to midterm effects of transrenal fixation of aortic stent-grafts on renal function in patients with abdominal aortic aneurysms. MATERIALS AND METHODS: A search of the PubMed, MEDLINE, and EMBASE databases for English-language literature was performed. Studies with at least 10 patients were included for data analysis. Only studies on transrenal fixation of aortic stent-grafts that included follow-up results for renal function were included. A log-linear model was used for meta-analysis to compare transrenal fixation with infrarenal fixation. RESULTS: Twenty-two studies met the inclusion criteria. Because two studies analyzed the same group of patients, one was excluded, for a total of 21 studies. Comparisons between transrenal fixation and infrarenal fixation were found in seven studies. For transrenal versus infrarenal fixation, the combined odds ratio, 95% confidence interval, and P value were found to be statistically significant with respect to postprocedural renal infarction only (combined odds ratio, 5.189; 95% confidence interval: 3.198, 8.420; P < .001). No significant difference was found between transrenal and infrarenal fixation with respect to renal dysfunction, renal artery occlusion, or endoleaks (P > .05). CONCLUSION: Transrenal fixation of aortic stent-grafts seems to be a relatively safe alternative compared with infrarenal fixation in terms of short- to midterm follow-up. Postprocedural renal infarction, however, was significantly higher for transrenal fixation.     

Tube Stent-Grafts for Infrarenal Aortic Aneurysm: A Matched-Paired Analysis Based on EUROSTAR Data

Objective Tube stent-grafts for treatment of infrarenal aortic aneurysms (AAAs) are a nearly forgotten concept. For focal aortic pathologies tube stent-grafts may be a treatment option. We have performed a retrospective matched-paired analysis of the EUROSTAR registry regarding the outcome of tube vs. bifurcated stent-grafts for AAA. Tapered aortomonoiliac stent-grafts were not the objective of this study. Materials and methods From July 1997 to June 2006, 7581 patients who underwent an endovascular AAA repair were entered in the EUROSTAR registry by 164 centers. One hundred fifty-three patients were treated with tube stent-grafts. For each of these 153 patients we selected one patient from a bifurcated stent-graft group (BGG-original, 7428 patients) matched according to gender, ASA, age, AAA diameter, and type of anesthesia. Differences in preoperative details between the two study groups were analyzed using chi-square test for discrete variables and Wilcoxon rank-sum test for continuous variables. Multivariate logistic regression analysis was performed on early complications. Midterm outcomes (>30 days) were analyzed by Kaplan-Meier and multivariate Cox proportional hazard model. Results The duration of the procedure was shorter in the tube stent-graft group (TGG; 102.3 ± 52.2) than in BGG (128.3 ± 55.0; p = 0.0002). Type II endoleak was less frequent in TGG (4.0%; mean follow-up, 23.12 ± 23.9 months) than in BGG (14.3%; mean follow-up, 20.77 ± 20.0 months; p = 0.0394). Type I endoleaks and migration were distributed equally, without significant differences between the groups. Combined 30-day and late mortality was higher for TGG (p = 0.0346) and was obviously not aneurysm related. Conclusions We conclude that after selection of patients, tube stent-grafts for infrarenal aortic repair can be performed with great safety regarding endoleaks and migration. The combined higher 30-day mortality and non-aneurysm-related mortality during follow-up were mainly caused by cardiac failures in our sample. On Behalf of the EUROSTAR Collaborators